HUANG JAMES purchased 19.0% of their position (44.53K shares) of CASI PHARMACEUTICALS, INC (DE) on the open market
Open‑market purchase worth $166.9K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/26/2022ACC: 0000899243-22-029897
+44.53K
Net shares
Net buyer
$166.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
44.53K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+5K
Price / share
$3.75
Trade value
$18.75K
% of position
2.1%
8/24/2022
234.22K→239.22K
Common Stock
Indirect
Shares
+39.53K
Price / share
$3.75
Trade value
$148.18K
% of position
16.5%
8/26/2022
239.22K→278.75K
Total
Net shares
+44.53K
Net value
$166.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/24/2022 | P · Purchase | +5K | $3.75 | $18.75K | 2.1% | 234.22K | 239.22K |
| Common Stock Indirect | 8/26/2022 | P · Purchase | +39.53K | $3.75 | $148.18K | 16.5% | 239.22K | 278.75K |
| Total | +44.53K | $166.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned191.00
Total
191.00 direct191.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 191.00 | Direct |
| Total | 191.00 | 191.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported